Preliminary data of the GORTEC 2000-02 phase III trial comparing intravenous and subcutaneous administration of amifostine for head and neck tumors treated by external radiotherapy.
about
Effect of amifostine in head and neck cancer patients treated with radiotherapy: a systematic review and meta-analysis based on randomized controlled trialsChemotherapy- and radiotherapy-induced oral mucositis: review of preventive strategies and treatment.Radiation-Induced Oral MucositisEfficacy and tolerability of amifostine in elderly cancer patientsOral mucositis induced by anticancer treatments: physiopathology and treatments.The optimal choice of medication administration route regarding intravenous, intramuscular, and subcutaneous injection.Commentary: the pharmacological antioxidant amifostine -- implications of recent research for integrative cancer care.Intrarectal amifostine during external beam radiation therapy for prostate cancer produces significant improvements in Quality of Life measured by EPIC score.Alternate delivery route for amifostine as a radio-/chemo-protecting agent.History and development of radiation-protective agents.Pharmacological interventions for preventing dry mouth and salivary gland dysfunction following radiotherapy.Sustained-release microspheres of amifostine for improved radio-protection, patient compliance, and reduced side effects.
P2860
Q28538411-FFAB0176-BDF1-4B31-8C5F-7986C99F6641Q33217865-80C1BB63-97B9-4EBE-9E9E-881D7928B9C0Q33711362-32512E65-F9EB-4FC2-99C9-945D106CB0C7Q33738758-DD06CCBB-35EA-4B58-900B-4B28DD50C912Q35166803-3A2DD2F6-1374-49B0-8F20-851B46CA3AA8Q35827701-F8915C42-D878-45E3-952B-62CAB517C389Q36390553-7294B6D2-087D-4E62-AE61-FE9AB97D86D3Q36495325-F2EA6861-08CD-4DAD-B139-3AA7D8DC5F00Q37189789-7333C915-C0F6-40F7-88EE-0B3A9749C8EFQ37532178-04218935-25B5-49A6-83B6-47D233509229Q38651513-06801B35-EEAC-45D2-A560-ACB749BFB3E6Q50223842-51D436A6-60CD-4A54-A494-76CC26260B56
P2860
Preliminary data of the GORTEC 2000-02 phase III trial comparing intravenous and subcutaneous administration of amifostine for head and neck tumors treated by external radiotherapy.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Preliminary data of the GORTEC ...... ated by external radiotherapy.
@ast
Preliminary data of the GORTEC ...... ated by external radiotherapy.
@en
type
label
Preliminary data of the GORTEC ...... ated by external radiotherapy.
@ast
Preliminary data of the GORTEC ...... ated by external radiotherapy.
@en
prefLabel
Preliminary data of the GORTEC ...... ated by external radiotherapy.
@ast
Preliminary data of the GORTEC ...... ated by external radiotherapy.
@en
P2093
P356
P1433
P1476
Preliminary data of the GORTEC ...... ated by external radiotherapy.
@en
P2093
Béatrix Rhein
Claude Tuchais
Etienne Bardet
Gilles Calais
Jean Bourhis
Laurent Martin
Marc Alphonsi
Nouredine Feham
P356
10.1053/SONC.2002.37348
P433
6 Suppl 19
P577
2002-12-01T00:00:00Z